image credit- freepik
Japan-based Global Health Innovative Technology (GHIT) Fund and Thailand Science Research and Innovation (TSRI) have signed a memorandum of understanding (MOU) to strengthen their partnership through co-funding opportunities for research and development (R&D) targeting malaria, tuberculosis, neglected tropical diseases (NTDs), and other infectious diseases with pandemic potential.
TSRI is a government agency under Thailand's Ministry of Higher Education, Science, Research and Innovation that promotes research and innovation by establishing the National Plan and Policy for Science, Research and Innovation (SRI) in Thailand, and allocating the SRI budget (Thailand RISE Fund) to government agencies, universities, research institutions, and other organisations in line with national strategies.
The partnership will focus on promotion of product development for drugs, vaccines, and diagnostics targeting malaria, tuberculosis, NTDs, and other infectious diseases with pandemic potential through co-funding opportunities for R&D projects conducted by Thai institutions or implemented in Thailand; Enhancement of research and innovation ecosystems in both Thailand and Japan, fostering further progress in infectious disease research and development; and Facilitation of knowledge sharing and capacity building through joint workshops and collaborative networks focusing on NTDs and related infectious diseases.
Through this strengthened partnership, additional funding opportunities will be made available to Thai universities, research institutes, and companies, as well as to global research partners conducting project activities in Thailand. This partnership builds on Thailand's world-leading expertise in parasitic and infectious disease research, including malaria and NTDs.
